← United States · Coverage record
US · SEC FORM 4
Arcellx, Inc.
ACLX · — · CIK 0001786205 · Healthcare
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
12 Form 4 transaction lines observed in the same window
0 sales · 12 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2022-06-21 · BASKETT FOREST; Florence Anthony A. Jr.; Makhzoumi Mohamad; NEA 15 GP, LLC; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; SANDELL SCOTT D; Sonsini Peter W..
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context capture is under review for ACLX. Last attempt: 2026-10-18T21:13:29.333117+00:00. —
Short interest
The FINRA report lists no short interest for this ticker.
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2022-06-21 | BASKETT FOREST; Florence Anthony A. Jr.; Makhzoumi Mohamad; NEA 15 GP, LLC; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; SANDELL SCOTT D; Sonsini Peter W. | Purchase (P) | Common Stock | 312,500 | USD 16.00 | USD 5,000,000 | SEC filing ↗ |
| 2022-02-08 | George Simeon; SR ONE CAPITAL MANAGEMENT, LLC; SR ONE CAPITAL PARTNERS I, LP; SR One Capital Fund I Aggregator LP; SR One Co-Invest II Manager, LLC; SR One Co-Invest II, LLC | Purchase (P) | Common Stock | 1,666,667 | USD 15.00 | USD 25,000,005 | SEC filing ↗ |
| 2022-02-08 | Novo Holdings A/S | Purchase (P) | COMMON STOCK | 833,333 | USD 15.00 | USD 12,499,995 | SEC filing ↗ |
| 2022-02-08 | Carroll Jill | Purchase (P) | Common Stock | 1,666,667 | USD 15.00 | USD 25,000,005 | SEC filing ↗ |
| 2022-02-08 | BASKETT FOREST; Florence Anthony A. Jr.; Makhzoumi Mohamad; NEA 15 GP, LLC; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; SANDELL SCOTT D; Sonsini Peter W. | Purchase (P) | Common Stock | 1,583,333 | USD 15.00 | USD 23,749,995 | SEC filing ↗ |
Form 4 evidence
49 transaction lines in the latest 365-day window; 361 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Lubner David Charles | U (U) | Common Stock | 21,659 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Heery Christopher | U (U) | Common Stock | 23,749 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Gilson Michelle | U (U) | Common Stock | 72,048 | USD — | USD — | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-04-28 | Lubner David Charles | U (U) | Common Stock | 21,659 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Heery Christopher | U (U) | Common Stock | 23,749 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Gilson Michelle | U (U) | Common Stock | 72,048 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Galligan Andrew H | U (U) | Common Stock | 5,000 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Elghandour Rami | U (U) | Common Stock | 692,551 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Carroll Jill | U (U) | Common Stock | 1,479,148 | USD — | USD — | SEC filing ↗ |
| 2026-04-28 | Behbahani Ali | U (U) | Common Stock | 4,631 | USD — | USD — | SEC filing ↗ |
| 2026-04-16 | Gilson Michelle | Option exercise / conversion (M) | Common Stock | 2,110 | USD 8.66 | USD 18,273 | SEC filing ↗ |
| 2026-04-15 | Gilson Michelle | Option exercise / conversion (M) | Common Stock | 36,000 | USD 8.66 | USD 311,760 | SEC filing ↗ |
| 2026-03-17 | Gilson Michelle | Gift (G) | Common Stock | 5,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-04 | Elghandour Rami | Gift (G) | Common Stock | 101,164 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-27 | Elghandour Rami | Sale (S) | Common Stock | 89,916 | USD 113.92 | USD 10,243,231 | SEC filing ↗ |
| 2026-02-25 | Gilson Michelle | Sale (S) | Common Stock | 11,219 | USD 113.82 | USD 1,276,947 | SEC filing ↗ |
| 2026-02-19 | Gilson Michelle | Sale (S) | Common Stock | 8,384 | USD 68.29 | USD 572,554 | SEC filing ↗ |
| 2026-02-17 | Gilson Michelle | Sale (S) | Common Stock | 11,291 | USD 69.50 | USD 784,770 | SEC filing ↗ |
| 2026-02-11 | Elghandour Rami | Gift (G) | Common Stock | 198,000 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-02-11 | Elghandour Rami | Gift (G) | Common Stock | 218,500 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-20 | Lubner David Charles | Sale (S) | Common Stock | 6,000 | USD 75.00 | USD 450,000 | SEC filing ↗ |
| 2026-01-20 | Lubner David Charles | Option exercise / conversion (M) | Common Stock | 6,000 | USD 6.28 | USD 37,680 | SEC filing ↗ |
| 2026-01-14 | Heery Christopher | Sale (S) | Common Stock | 5,882 | USD 68.51 | USD 402,976 | SEC filing ↗ |
| 2026-01-13 | Heery Christopher | Sale (S) | Common Stock | 7,437 | USD 65.51 | USD 487,198 | SEC filing ↗ |
| 2026-01-12 | Heery Christopher | Sale (S) | Common Stock | 6,131 | USD 64.15 | USD 393,304 | SEC filing ↗ |
| 2026-01-06 | Elghandour Rami | Option exercise / conversion (M) | Common Stock | 55,991 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Gilson Michelle | Option exercise / conversion (M) | Common Stock | 20,530 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Heery Christopher | Option exercise / conversion (M) | Common Stock | 13,064 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Heery Christopher | Option exercise / conversion (M) | Common Stock | 13,064 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Gilson Michelle | Option exercise / conversion (M) | Common Stock | 20,530 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-06 | Elghandour Rami | Option exercise / conversion (M) | Common Stock | 55,991 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-03 | Elghandour Rami | Option exercise / conversion (M) | Common Stock | 53,098 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-01-03 | Gilson Michelle | Option exercise / conversion (M) | Common Stock | 15,340 | USD 0.00 | USD 0 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | ACLX |
| CIK | 0001786205 |
| Sector | Healthcare |
| Industry | — Yahoo Finance |
| SEC SIC | 2836 Biological Products, (No Diagnostic Substances) |
| Exchange | — |
Data coverage
| Local Form 4 history | 361 transaction lines from 2022-02-08 to 2026-04-28 7 P purchase lines · 187 S sale lines · 167 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.